Generic Name: guaifenesin
Dosage Form: tablet, extended release
MAXIMUM STRENGTH
Mucinex ®
Drug Facts
Active ingredient (in each extended-release bi-layer tablet)
Guaifenesin 1200 mg
Purpose
Expectorant
Uses
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Warnings
Do not use
- for children under 12 years of age
Ask a doctor before use if you have
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- cough accompanied by too much phlegm (mucus)
Stop use and ask a doctor if
- cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- do not crush, chew, or break tablet
- take with a full glass of water
- this product can be administered without regard for the timing of meals
- adults and children 12 years of age and over: 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours.
- children under 12 years of age: do not use
Other information
- tamper evident: do not use if carton is open or if printed seal on blister is broken or missing
- store between 20-25°C (68-77°F)
Inactive ingredients
carbomer 934P, NF; FD&C blue #1 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
Questions?
1-866-MUCINEX (1-866-682-4639) You may also report side effects to this phone number.
Dist. by: Reckitt Benckiser Inc.
Parsippany, NJ 07054-0224
PRINCIPAL DISPLAY PANEL - 1200 mg Tablet Carton
MAXIMUM STRENGTH
NDC 63824-023-36
Mucinex®
1200 mg guaifenesin extended-release bi-layer tablets
EXPECTORANT
12
HOUR
- ✔
- Thins And Loosens Mucus
- ✔
- Relieves Chest Congestion
28 EXTENDED-RELEASE BI-LAYER TABLETS
MUCINEX MAXIMUM STRENGTH guaifenesin tablet, extended release | ||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA021282 | 08/11/2009 |
Labeler - Reckitt Benckiser, Inc. (094405024) |
More Mucinex Maximum Strength resources
- Mucinex Maximum Strength Side Effects (in more detail)
- Mucinex Maximum Strength Use in Pregnancy & Breastfeeding
- Drug Images
- Mucinex Maximum Strength Support Group
- 51 Reviews for Mucinex Maximum Strength - Add your own review/rating
Compare Mucinex Maximum Strength with other medications
- Bronchitis
- Cough
- Fibromyalgia
No comments:
Post a Comment